Shares Of Zafgen Fell 60% After Reporting Another Patient Death For Obesity Trial

The obesity trial is being turn to treat patients with a rare disease known as Prader-Will Syndrome. This syndrome causes the ability for patients to be hungry all the time, which causes the foundation for long-term obesity.